Sergio Rodríguez-Rodríguez

7PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersAutoimmunityRespiratory diseasesCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

|Jun 26, 2026
Combined Obstetric and Thrombotic Complications Are Associated with Features Suggestive of an Immune-Enriched Phenotype Among Women with Thrombotic Antiphospholipid Syndrome (APS).

|Apr 17, 2026
Lung Biopsies in Patients Referred for Allogeneic Hematopoietic Cell Transplantation: Diagnostic Accuracy, Diagnostic Yield, and Clinical Utility.

|Oct 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.

Sergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux

|Sep 14, 2025
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment.

Sergio Rodriguez-Rodriguez, Nihar Desai, Carol Chen

|Jul 13, 2023
Are accessory spleen screening and resection in refractory immune cytopenia an effective strategy or a waste of resources?

Sergio Rodríguez-Rodríguez, José Miguel Álvarez-Blanco, Susana Sánchez-Díaz

Pageof 2

Frequent Collaborators

3 joint publications

Jonas Mattsson

3 joint publications

Nihar Desai

3 joint publications

Arjun Law

3 joint publications

Dennis Dong Hwan Kim